Search Result "swissADME"
In silico ADME/Pharmacokinetic and Target Prediction Studies ofEthambutol as Drug Molecule
Journal: Infectious Disorders - Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 12-18
Author(s): Arnav Ajinkya Joshi,Sakshi V. Khairnar,Hemchandra K. Chaudhari
Antioxidant, Cytotoxic Activity and Pharmacokinetic Studies by SwissAdme, Molinspiration, Osiris and DFT of PhTAD-substituted DihydropyrroleDerivatives
Journal: Current Computer-Aided Drug Design
Volume: 18 Issue: 1 Year: 2022 Page: 52-63
Author(s): Arif Ayar,Masuk Aksahin,Seda Mesci,Burak Yazgan,Melek Gül,Tuba Yıldırım
In Search of HIV Entry Inhibitors Using Molecular Docking, ADME, andToxicity Studies of Some Thiazolidinone-Pyrazine Derivatives AgainstCXCR4 Co-receptor
Journal: Current HIV Research
Volume: 20 Issue: 2 Year: 2022 Page: 152-162
Author(s): Shital M. Patil,Kalyani D. Asgaonkar,Trupti S. Chitre
Target Based Virtual Screening of New Leads Inhibitor against Bacterial Cell Division Protein FtsZ for the Discovery of Antibacterial Agents
Journal: Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2020 Page: 169-175
Author(s): Ratish C. Mishra,Rosy Kumari,Shivani Yadav,Jaya P. Yadav
In silico Analysis and Molecular Docking Studies of Novel 4-Amino-3- (Isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]Pyrimidine Derivatives as Dual PI3-K/mTOR Inhibitors
Journal: Current Drug Discovery Technologies
Volume: 16 Issue: 3 Year: 2019 Page: 297-306
Author(s): Ishan I. Panchal,Sandip N. Badeliya,Rakesh Patel,Ashish Patel,Animesh Devaligar
ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for theAspect of Anticancer & Anti-inflammatory Potency
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2023 Page: 1499-1505
Author(s):
Advances in In-silico based Predictive In-Vivo Profiling of Novel Potent β- Glucuronidase Inhibitors
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 906-918
Author(s): Maria Yousuf
Discovering Drug Candidates for Charcot Marie Tooth Disease Type-2
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 13 Year: 2024 Page: 2483-2489
Author(s): Fahad Hassan Shah,Young Seok Eom,Song Ja Kim
Molecular Modeling of some 1,3,4-Oxadiazole Derivatives as EGFRInhibitors for the Treatment of Cancer
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 10 Year: 2024 Page: 1694-1706
Author(s): Shital M. Patil,Shashikant V. Bhandari,Varsha A. Patil
Designing and In silico Studies of Novel Hybrid of 1,3,4-oxadiazolechalconeDerivatives as EGFR Inhibitors
Journal: Current Drug Discovery Technologies
Volume: 20 Issue: 6 Year: 2023 Page: 47-59
Author(s): Shital M Patil